Ari Zimran
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multicenter, Safety and Efficacy Study of Taliglucerase Alfa in Subjects With Type 3 Gaucher Disease (NCT04002830) | Ari Zimran | 2020-11-20 |
Track Ari Zimran automatically
Every clearance here is in the API, with alerts when new ones post.